These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 169139)

  • 1. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adenosine-3',5'-monophosphate phosphodiesterase of the cerebral cortex and the effect of cardiovascular preparations].
    Libinzon RE; Shchekoldina TG; Batolkina OE; Iagniatinskaia AM
    Vopr Med Khim; 1977; 23(4):526-30. PubMed ID: 200004
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioural effects of selective PDE4 inhibitors in relation to inhibition of catalytic activity and competition for [3H]rolipram binding.
    Kapui Z; Bence J; Boronkay E; Mikus E; Urbán Szabó K; Baranyi A; Arányi P
    Neurobiology (Bp); 1999; 7(1):71-3. PubMed ID: 10746252
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB; Wilkinson RG
    Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
    J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
    Green D; Guy G; Moore JB
    Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
    Tateson JE; Trist DG
    Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695
    [No Abstract]   [Full Text] [Related]  

  • 11. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity.
    Hayashi S; Ozawa H
    Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):810-6. PubMed ID: 171085
    [No Abstract]   [Full Text] [Related]  

  • 12. Reticulol, an inhibitor of cyclic adenosine 3', 5'-monophosphate phosphodiesterase.
    Furutani Y; Shimada M; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1975 Jul; 28(7):558-60. PubMed ID: 168174
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa.
    Klotz U; Antonin KH; Bieck P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modulation of reactivity of cyclic adenosine monophosphate phosphodiesterase under the effect of pyridinecarboxylic acid derivatives and Pt(IV) metal complexes on their basis].
    Tat'ianenko LV; Bogdanov GN; Dobrokhotova OV; Fadeev MA; Fedorov BS
    Biomed Khim; 2006; 52(2):174-9. PubMed ID: 16805389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylxanthine and non-xanthine phosphodiesterase inhibitors. Their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte.
    Wong EH; Ooi SO
    Biochem Pharmacol; 1985 Aug; 34(16):2891-6. PubMed ID: 2411270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL; Garst JE; Mitchel SS; Wells JN
    Biochemistry; 1977 Jul; 16(15):3316-21. PubMed ID: 196632
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.
    Kreutner W; Sherwood JE
    Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.